ImmunoMind (graduated from UC Berkeley SkyDeck) helps companies and medical centres design and produce safer and more effective CAR-T and other Cell Therapies, leveraging a proprietary multi-omics database of immune cells and AI. This collaboration connects eLabNext users to the ImmunoMind platform and enhances reporting in eLabJournal by using results from multi-omics-driven drug development and manufacturing.
The ImmunoMind add-on identifies both cell subpopulations (e.g. Tscm, Tcm, Tem, Treg, NK, gdT cells) and their characteristics (e.g. exhaustion, senescence, activation) to create a comprehensive profile of CAR-T and other Cell Therapy products.
Enhance compliance and convenience by creating a custom approval workflows for signing and witness signing of experiments per project.Learn more
Accelerate your drug design process with cutting-edge in silico toxicity assessmentLearn more
Please note: This add-on is currently only available for cloud users. It will be available for dedicated installations on the…Learn more